. 2021 Feb 2;2(1):1–6. doi: 10.1530/RAF-20-0030
This work is licensed under a Table 1.
Background of the two groups (LDM vs NLDM) for all ages. Data are presented as n (%) or mean ± S.D. Statistically significant value is in bold.
| LDM | NLDM | P value | |
|---|---|---|---|
| No. of patients | 48 | 68 | – |
| Age (years) | 38.5 ± 4.45 | 38.4 ± 3.44 | 0.8659a |
| Previous embryo transfer | 1.52 ± 0.68 | 1.37 ± 0.71 | 0.2404a |
| Multigravida patients | 21 (43.8%) | 35 (51.5%) | 0.3691b |
| Multipara patients | 8 (16.7%) | 22 (32.4%) | 0.0515b |
| Patients with miscarriage | 18 (37.5%) | 18 (26.5%) | 0.2252b |
| Patients with chronic endometriosis | 5 (10.4%) | 14 (20.6%) | 0.3598b |
| Patients with endometriosis | 3 (6.3%) | 4 (5.9%) | 0.9347b |
| Patients with endometrial polyp | 5 (10.4%) | 4 (5.9%) | 0.3746b |
| Serum AMH (ng/mL) | 3.19 ± 2.94 | 3.61 ± 2.65 | 0.4300a |
| Serum TSH >2.50 (μIU/mL) | 9 (18.8%) | 10 (14.7%) | 0.4809b |
| % of endometrial Lactobacillus* | 99.4 (92.3–100) | 5.8 (0.0–89.7) | - |
aStudent’s t-test; bChi-square test; *Values are presented as median (range).
AMH, anti-mullerian hormone; LDM, Lactobacillus-dominated microbiota; NLDM, non--dominated microbiota; TSH, thyroid stimulating hormone.